Agile Therapeutics, Inc. announced the appointment of Paul Korner, MD, MBA, to the position of Chief Medical Officer. Dr. Korner is a board-certified obstetrician and gynecologist with more than 20 years of pharmaceutical and biotech industry experience, including significant experience within women's healthcare. He will be responsible for supporting the commercial launch of Twirla®, advancing the Company's internal pipeline and evaluating external growth opportunities. Dr. Korner will report to Al Altomari, Agile's Chairman and Chief Executive Officer. Dr. Korner has served in various leadership positions of increasing responsibility at several global companies focused on female reproductive health, including Solvay Pharmaceuticals, Wyeth Research, Bayer, and Ferring Pharmaceuticals. He currently serves on the Laidlaw Venture Partners Scientific Advisory Board and the Board of Directors of Voltron Therapeutics as an Independent Director.